454 related articles for article (PubMed ID: 26408170)
1. Endocannabinoids and the Digestive Tract and Bladder in Health and Disease.
Izzo AA; Muccioli GG; Ruggieri MR; Schicho R
Handb Exp Pharmacol; 2015; 231():423-47. PubMed ID: 26408170
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction.
Hedlund P
Neurourol Urodyn; 2014 Jan; 33(1):46-53. PubMed ID: 24285567
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids: potential targets for bladder dysfunction.
Ruggieri MR
Handb Exp Pharmacol; 2011; (202):425-51. PubMed ID: 21290238
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.
Taschler U; Hasenoehrl C; Storr M; Schicho R
Handb Exp Pharmacol; 2017; 239():343-362. PubMed ID: 28161834
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.
Alhouayek M; Muccioli GG
Trends Mol Med; 2012 Oct; 18(10):615-25. PubMed ID: 22917662
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review.
Hryhorowicz S; Kaczmarek-Ryś M; Zielińska A; Scott RJ; Słomski R; Pławski A
Front Immunol; 2021; 12():790803. PubMed ID: 35003109
[TBL] [Abstract][Full Text] [Related]
7. The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.
Hasenoehrl C; Taschler U; Storr M; Schicho R
Neurogastroenterol Motil; 2016 Dec; 28(12):1765-1780. PubMed ID: 27561826
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids and the gut: new developments and emerging concepts.
Izzo AA; Sharkey KA
Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoids and the gastrointestinal tract.
Massa F; Monory K
J Endocrinol Invest; 2006; 29(3 Suppl):47-57. PubMed ID: 16751708
[TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract.
Massa F; Storr M; Lutz B
J Mol Med (Berl); 2005 Dec; 83(12):944-54. PubMed ID: 16133420
[TBL] [Abstract][Full Text] [Related]
11. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.
Patil AS; Mahajan UB; Agrawal YO; Patil KR; Patil CR; Ojha S; Sharma C; Goyal SN
Biomed Pharmacother; 2020 Dec; 132():110889. PubMed ID: 33113429
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
Di Carlo G; Izzo AA
Expert Opin Investig Drugs; 2003 Jan; 12(1):39-49. PubMed ID: 12517253
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoids in the gastrointestinal tract.
Lee Y; Jo J; Chung HY; Pothoulakis C; Im E
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G655-G666. PubMed ID: 27538961
[TBL] [Abstract][Full Text] [Related]
14. Targeting the endocannabinoid system: future therapeutic strategies.
Aizpurua-Olaizola O; Elezgarai I; Rico-Barrio I; Zarandona I; Etxebarria N; Usobiaga A
Drug Discov Today; 2017 Jan; 22(1):105-110. PubMed ID: 27554802
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid pharmacology and therapy in gut disorders.
Uranga JA; Vera G; Abalo R
Biochem Pharmacol; 2018 Nov; 157():134-147. PubMed ID: 30076849
[TBL] [Abstract][Full Text] [Related]
16. The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome.
Storr MA; Yüce B; Andrews CN; Sharkey KA
Neurogastroenterol Motil; 2008 Aug; 20(8):857-68. PubMed ID: 18710476
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoids in the treatment of gasytrointestinal inflammation and symptoms.
Pesce M; Esposito G; Sarnelli G
Curr Opin Pharmacol; 2018 Dec; 43():81-86. PubMed ID: 30218940
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects.
Izzo AA; Camilleri M
Gut; 2008 Aug; 57(8):1140-55. PubMed ID: 18397936
[TBL] [Abstract][Full Text] [Related]
19. Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases.
Schicho R; Storr M
Can J Gastroenterol; 2011 Jul; 25(7):377-83. PubMed ID: 21876860
[TBL] [Abstract][Full Text] [Related]
20. No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids.
Hu SS; Ho YC; Chiou LC
Eur J Neurosci; 2014 Feb; 39(3):467-84. PubMed ID: 24494686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
